Benchmark Research - Fort Worth - HyperCore -PPDS

Fort Worth, Texas 76135-5283

0 studies enrolling now · 3 studies all time

What they study most

Cytomegalovirus, Epstein-Barr Virus Infection, Respiratory Syncytial Virus

Studies at this site

• A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age — Completed
• A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults — Running, not enrolling
• A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults — Running, not enrolling